← Back to patent-cliff list

Telatinib

Tier C — Watch / trade

Telatinib

Bayer
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:KIT, VEGFR3, PDGFR-β, VEGFR2

Indications (approved):Gastric cancer, Solid tumour

Regional status

US
No progress
2009-06-01
EU
No progress
2009-06-01
China
Phase II
2018-12-26
Japan
-

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 6 · Total yield 6.73 g (Telatinib)
TELA-00188-14-2TELA-0024282-24-0TELA-00352900-79-5TELA-00413177-71-4TELA-00513177-70-3TELA-006106-47-8TELA-007332013-40-8TELA-008332013-43-1API · Telatinib
CodeCAS No.Intermediate
TELA-00188-14-2furan-2-carboxylic acid
TELA-0024282-24-0furan-2,3-dicarboxylic acid
TELA-00352900-79-5dimethyl furan-2,3-dicarboxylate
TELA-00413177-71-45,6-dihydrofuro[2,3-d]pyridazine-4,7-dione
TELA-00513177-70-34,7-dichlorofuro[2,3-d]pyridazine
TELA-006106-47-84-chloroaniline
TELA-007332013-40-87-chloro-N-(4-chlorophenyl)furo[2,3-d]pyridazin-4-amine
TELA-008332013-43-14-(hydroxymethyl)-N-methylpicolinamide

Frequently asked questions

What are the approved indications of Telatinib?

Approved indications include: Gastric cancer, Solid tumour.

When does the Telatinib patent expire?

No public expiry year is available for Telatinib yet; this page updates once verified.

How many synthesis routes are recorded for Telatinib?

1 synthesis routes are recorded; the shortest is 6 steps with 6.73 g (Telatinib) total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Telatinib intermediates?

All intermediates in Telatinib routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Telatinib intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-21